STATE STREET CORP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,254,559
-11.3%
212,370
-0.1%
0.00%
Q2 2023$8,183,175
+10.2%
212,550
+2.5%
0.00%
Q1 2023$7,424,700
-52.3%
207,456
-47.5%
0.00%
Q4 2022$15,569,802
+153.2%
394,872
+131.8%
0.00%
Q3 2022$6,150,000
+2.5%
170,371
-13.6%
0.00%
Q2 2022$5,999,000
+14.1%
197,221
+14.7%
0.00%
Q1 2022$5,258,000
+4.4%
171,987
+6.7%
0.00%
Q4 2021$5,037,000
+123.6%
161,249
+9.4%
0.00%
Q3 2021$2,253,000
-7.4%
147,447
+12.9%
0.00%
Q2 2021$2,432,000
+38.5%
130,595
+33.1%
0.00%
Q1 2021$1,756,000
+22.3%
98,088
+5.0%
0.00%
Q4 2020$1,436,000
+44.9%
93,386
+4.3%
0.00%
Q3 2020$991,000
-8.8%
89,547
+3.3%
0.00%
Q2 2020$1,087,000
+405.6%
86,664
+356.7%
0.00%
Q1 2020$215,000
-19.5%
18,978
-6.8%
0.00%
Q4 2019$267,000
+43.5%
20,360
-1.5%
0.00%
Q3 2019$186,000
-8.8%
20,6640.0%0.00%
Q2 2019$204,000
-2.9%
20,6640.0%0.00%
Q1 2019$210,000
+56.7%
20,664
-2.9%
0.00%
Q4 2018$134,000
-47.9%
21,288
+9.2%
0.00%
Q3 2018$257,00019,5000.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders